Yael Glickman has over 15 years of managerial experience in the BioMed and BioTech industries, where she played major roles in the development and commercialization of medical devices and biotech products.

She has recently served as CEO of Kolmir, a Hutchison Kinrot portfolio company, and as Vice President at Deepbreeze, heading the Strategic Business Unit for Intensive Care.

More recently, she has established and managed a technological incubator at ECE Paris.

She is now VP Business Development in a biotech company in Tel Aviv.

Yael holds a PhD from the Weizmann Institute and an MBA from the Technion Institute of Technology.